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Abstract
Selenoproteins are a unique group of proteins that contain selenium in the form of seleno-
cysteine (Sec) co-translationally inserted in response to a UGA codon with the help of cis-
and trans-acting factors. Mammalian selenoproteins contain single Sec residues, with the
exception of selenoprotein P (SelP) that has 7–15 Sec residues depending on species.
Assessing an individual’s selenium status is important under various pathological condi-
tions, which requires a reliable selenium biomarker. Due to a key role in organismal sele-
nium homeostasis, high Sec content, regulation by dietary selenium, and availability of
robust assays in human plasma, SelP has emerged as a major biomarker of selenium sta-
tus. Here, we found that Cys is present in various Sec positions in human SelP. Treatment
of cells expressing SelP with thiophosphate, an analog of the selenium donor for Sec syn-
thesis, led to a nearly complete replacement of Sec with Cys, whereas supplementation of
cells with selenium supported Sec insertion. SelP isolated directly from human plasma had
up to 8% Cys inserted in place of Sec, depending on the Sec position. These findings sug-
gest that a change in selenium status may be reflected in both SelP concentration and its
Sec content, and that availability of the SelP-derived selenium for selenoprotein synthesis
may be overestimated under conditions of low selenium status due to replacement of Sec
with Cys.
Introduction
Selenium (Se) is an essential microelement [1,2,3]. In mammals, it is present primarily within
selenoproteins in the form of selenocysteine (Sec) [4]. Sec is encoded by a UGA codon and
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becomes inserted into selenoproteins by a set of specific cis- and trans-acting factors. The
human selenoproteome is encoded by 25 selenoprotein genes [5], and the majority of seleno-
proteins with known functions are oxidoreductases, in which Sec is located in catalytic sites
[6].
One mammalian selenoprotein, selenoprotein P (SelP, SEPP1), is different from other sele-
noproteins in that it has multiple Sec residues [7]. This protein is composed of an N-terminal
thioredoxin domain containing one Sec and a C-terminal Sec-rich region containing from 6
(e.g., in the naked mole rat) to 14 (e.g., in the dog) Sec residues [8]. SelP is primarily synthe-
sized by hepatocytes, secreted from liver and is the most abundant selenoprotein in plasma
[9,10]. SelP delivers Se, in the form of Sec, to other organs with receptors, such as ApoER2 and
megalin, that support SelP uptake [7]. The overall effect of having SelP is Se retention and
redistribution in the body. SelP-deficient mice are characterized by Se deficiency and can be
rescued by excess dietary Se [7,9].
SelP emerged as a biomarker of human Se status, because it is regulated by dietary Se within
a broad range of Se levels, and also because this selenoprotein can be readily assayed in human
plasma [11,12,13]. SelP also has a high Sec content and serves a key role in organismal selenium
homeostasis. The expression of SelP and its levels in human plasma were assumed to be directly
proportional to Se status following ingestion of normal and low amounts of dietary Se. How-
ever, quantification of Se in SelP containing 10 Sec codons yielded a selenium content of only
7.5 +/- 1.0 atoms/polypeptide in rat [14]. It has been unclear whether this decreased selenium
content is due to imperfect translation, premature translational termination, a loss of selenium
following protein synthesis or for other reasons.
In the current study, we found that Cys may be inserted in place of various Sec residues in
SelP. Under normal dietary intake, up to 8% of Sec residues are replaced with Cys in human
SelP, whereas in cell culture, the Sec/Cys ratio at the Sec sites is regulated by both Se status and
concentration of thiophosphate, leading to the Sec/Cys ratio from nearly zero to nearly one.
We discuss these data with regard to a possible overestimation of SelP-derived Sec availability
for selenoprotein biosynthesis under low Se status.
Materials and Methods
Reagents
HepG2 human hepatoma cells were from ATCC. Sodium selenite (Na2SeO3), sodium thiopho-
sphate (SPO3; formula Na3SPO3), iodoacetamide and DTT were from Sigma. Pierce HisPur
chromatography cartridge and monoclonal anti-hSelP antibodies were from Thermo Scientific.
Unless otherwise stated, all remaining reagents were from Sigma. 75Se isotope ([75Se]selenious
acid (specific activity, 1,000 Ci/mmol) was purchased from the Research Reactor Facility, Uni-
versity of Missouri (Columbia, MO).
Metabolic labeling of cells with 75Se, and supplementation of cells with
Se and thiophosphate
HepG2 cells were grown in high glucose DMEM supplemented with 10% fetal bovine serum
and antibiotic/antimycotic solution (all from Life Technology) at 37°C in 5% CO2 in 150 cm
2
flasks. Cells were split 1:4 the day before metabolic labeling in 10 cm dishes. Cells were incu-
bated for 24 h, then washed two times with PBS, and culture medium replaced with DMEM
without fetal bovine serum in the presence or absence of 100 nM of sodium selenite or 1 mM
of thiophosphate (final concentration), and labeled or not for 24 h with 10 μCi of 75Se freshly
neutralized with NaOH. Cells with only DMEM served as a control. Conditioned media and
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cells were collected separately. Media samples were concentrated in Amicon Ultra centrifugal
filter units with 10 kDa cut-off (Millipore). Cells were then resuspended in PBS and sonicated.
30 μg of total soluble protein from each cell lysate sample were resolved by SDS-PAGE and
transferred onto a PVDF membrane (Life Technology). Selenoprotein patterns were visualized
with a PhosphorImager. For large-scale SelP preparation, HepG2 cells were incubated in 15 cm
dishes in DMEM without serum with addition of 100 nM sodium selenite or 1 mM of thiopho-
sphate or with medium only. After 24–48 h, media samples were replaced with fresh medium
or the medium containing sodium selenite or thiophosphate. Conditioned media from differ-
ent incubations were pulled together resulting in about 250 ml of medium for each sample.
Isolation of human SelP from cell culture media
Secreted SelP was purified from HepG2 cell culture media using metal affinity chromatography
utilizing His-rich segments of SelP (Fig 1) as described [15]. Briefly, media samples were fil-
tered thought 0.2 μm filter and concentrated using Amicon Ultra centrifugal filters to a final
volume of ~10 ml. Next, media samples were equilibrated with loading buffer and SelP was
purified on HisPur 2 ml columns according to the manufacturer’s manual. Purification process
was monitored by SDS-PAGE andWestern blotting with anti-SelP antibodies. Imidazol elution
fractions were collected, dialyzed against PBS for 12 h, then concentrated to a final volume of
100–200 μl.
Isolation of human SelP from plasma
SelP was isolated from human plasma by affinity purification. A SelP-specific monoclonal anti-
body (2.6 mg, anti-SePP#7h6, ICI—immunochemical intelligence GmbH, Berlin, Germany)
was coupled to AminoLink1 Plus Coupling Gel (2 mL bed volume, Pierce Biotechnologies,
Inc., Rockford, IL). The protocol was approved by the ethics committee of the Charité-Univer-
sity Medicine Berlin (EA2/103/10) for healthy human probands, and we obtained the written
consent of the five donors used. The five human plasma samples (50 ml each) were pooled and
mixed with one volume of PBS, pH 8.0. Complete protease inhibitor cocktail tablets (n = 10,
Roche Applied Science) were added, the mixture was centrifuged at 1248×g (3000 rpm) for 10
min at 4°C, and consecutively filtered through 5 μm, 0.8 μm and finally 0.2 μm filters (Schlei-
cher & Schuell, Dassel, Germany). The filtrate was loaded by gravity flow onto the affinity col-
umn and washed with PBS, pH 8.0, until the OD280 of the flow-through was< 0.005. SelP was
eluted with citric acid, pH 2.0, in 15 fractions of 1 ml each. Each fraction was supplemented by
50 μL 1 M Tris, pH 8.8. The fractions with highest OD280 readings were combined (eluates
E2-E6), aliquoted and stored at -80°C. Aliquots of the initial, flow-through and eluate samples
were analyzed in a luminescence-based in-house immunoassay with two monoclonal mouse
anti-human SelP antibodies. The detection antibody was labeled with an acridinium ester. 26%
of the SelP sample-load was recovered in the eluates.
Liquid chromatography (LC)-MS/MS
Purified SelP samples were reduced with DTT, followed by alkylation of Cys and Sec residues
with iodoacetamide as described [16]. Alkylated proteins were resolved by SDS-PAGE using
Novex NU-PAGE system (Life Technology) and stained with Coomassie blue. Protein bands cor-
responding to SelP (individual samples representing the conditions analyzed in the current
study) were cut out and subjected to in-gel tryptic digestion and LC-MS/MS analysis. In-gel tryp-
sin digestion of the destained protein bands was carried out for 14 h at 37°C. The resulting pep-
tide mixture was extracted from the gel slices and loaded into a fused silica microcapillary packed
with Magic C18AQ beads (Michrom Bioresources). Reversed phase liquid chromatography was
Control of Selenocysteine Content of Selenoprotein P
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performed using an Agilent 1100 pump and a Famous autosampler (LC Packings). Peptides were
eluted from the column with a 90-min acetonitrile gradient and detected using an LTQ-Orbitrap
Velos (Thermo-Fisher Scientific).
Database analysis and quantification
MS/MS spectra were analyzed against a concatenated IPI_Human database (version 3.60)
(http://www.ebi.ac.uk/IPI/) using the Sequest algorithm (Version 28, Thermo-Fisher Scientific)
and a 0.5% false discovery rate. Database search criteria were as follows: two missed cleavages,
a precursor mass tolerance of 50 ppm, an MS/MS fragment ion tolerance of 0.8 Da, and the fol-
lowing variable modifications: oxidation (M), deamidation (NQ), and alkylation on Cys and
Sec. Peptide abundances were calculated using the area under the curve representing the entire
chromatographic peak of interest. The area under the curve for each Cys and Sec containing
form was divided by the sum of both forms to calculate a percent of the total peptide signal, as
previously carried out for thioredoxin reductase 1 [16].
Results
Characterization of SelP secreted by HepG2 cells
Human SelP has two His-rich segments (Fig 1), which can be employed for isolation of native
SelP using metal affinity chromatography [15]. As SelP is largely expressed in hepatocytes and
secreted into the blood stream [9,10,16,17], we used human hepatoma HepG2 cells as a source
of SelP. Cells were grown in DMEM, or in medium supplemented with 100 nM sodium selenite
(as a source of Se) or 1 mM thiophosphate (SPO3), and expression of SelP and other selenopro-
teins was analyzed by metabolic labeling of cells with 75Se (Fig 2A). This experiment revealed a
75Se labeling pattern typical of mammalian cells. As expected, these cells secreted 75Se-labeled
SelP, and we also found that they secreted glutathione peroxidase 3 (GPx3). SelP was the most
abundant secreted selenoprotein. The presence of SelP in media samples was confirmed by
Western blotting with anti-SelP antibodies (Fig 2B). As expected, SelP was not detected in cells,
because it was rapidly secreted following maturation and accumulated in cell culture media.
The method allowed distinguishing SelP from cellular selenoproteins, such as thioredoxin
reductase 1, which exhibit similar migration properties on SDS-PAGE gels.
We have shown previously that 1 mM thiophosphate did not significantly affect the growth
of NIH 3T3 cells, but could dramatically influence Sec insertion into thioredoxin reductases
Fig 1. Human SelP sequence. Positions of the ten Sec residues are indicated by numbers and shown in red. Positions of Cys residues are highlighted in
bold. Natural His-rich segments, which allow affinity isolation of human SelP, are underlined.
doi:10.1371/journal.pone.0140353.g001
Control of Selenocysteine Content of Selenoprotein P
PLOSONE | DOI:10.1371/journal.pone.0140353 October 9, 2015 4 / 9
[16]. Interestingly, 100 nM sodium selenite dramatically decreased incorporation of the radio-
active tracer into selenoproteins, apparently due to competition of “cold” Se with 75Se (Fig 2A).
Despite inefficient labeling of cells in the presence of sodium selenite, SelP was detected by
Western blotting (Fig 2B). This analysis also revealed that SelP secreted from HepG2 cells was
present in two major forms differing in molecular weight, apparently due to differential N-gly-
cosylation levels, as shown previously [18,19]. Gels were stained with Coomassie blue as load-
ing control (Fig 2C). We carried out isolation of SelP secreted from HepG2 cells using metal
affinity chromatography, which revealed significant enrichment of this protein, represented by
two bands (see below). A similar two-band pattern was observed for SelP isolated from human
plasma (Fig 2D). Subsequent MS/MS analysis of proteins isolated from gels revealed that both
bands contained full-length human SelP. Overall, these analyses demonstrated robust expres-
sion of SelP by HepG2 cells and its amenability to affinity chromatography.
For large-scale preparation of SelP from HepG2 cells, approximately 250 ml of conditioned
DMEMmedia were collected for each experimental condition. Filtered and concentrated
media samples were subjected to metal-affinity purification using natural His-rich segments of
SelP. Purification was monitored by Western blotting with anti-SelP antibodies (Fig 3, upper
panels). Fractions containing SelP were pulled together and analyzed by LC-MS/MS. Protein
flow through was assessed by Coomassie blue staining (Fig 3, lower panels). The conditions of
small- and large-scale isolations were slightly different, so the patterns of elution cannot be
directly compared, but both procedures worked sufficiently well to enrich SelP for subsequent
analyses.
Selenite and thiophosphate modulate Sec to Cys ratio at multiple
positions in SelP
We previously found that Cys can be inserted in place of Sec in thioredoxin reductases (TRs) in
a process that required a UGA codon and a SECIS element [15]. In addition, thiophosphate
Fig 2. SelP expression in hepatocytes and its regulation by selenium and thiophosphate. (A) HepG2 cells were cultured without or with 100 nM Se or 1
mM thiophosphate (SPO3), metabolically labeled with 75Se, and cell lysates and culture media samples analyzed by SDS-PAGE and PhosphorImager for
selenoprotein expression. Positions of SelP and GPx3 are indicated by arrows on the right, and protein molecular weight markers are indicated on the left. (B)
Samples from panel A were analyzed byWestern blotting (WB) with anti-SelP antibodies. Positions of protein molecular weight markers are indicated on the
left and SelP is indicated by arrows on the right. (C) Coomassie blue (CBB) staining of samples from A and B, used as a loading control. (D) SelP isolated
from human blood was analyzed by SDS-PAGE and stained with Coomassie blue. Protein molecular weights markers in kDa are shown on the left. Positions
of different SelP forms are indicated by arrows. Position of serum albumin is indicated by an asterisk.
doi:10.1371/journal.pone.0140353.g002
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could replace selenophosphate as a substrate for Sec synthase (SecS), an enzyme responsible
for the final step of Sec biosynthesis [20]. To examine the possibility that Cys replaces Sec in
SelP, this protein was isolated from control, selenite-supplemented and thiophosphate-supple-
mented cells and subjected to LC-MS/MS analysis, examining all ten Sec positions in human
SelP. Sample quality and content allowed quantitative estimation of Sec to Cys replacement at
Sec positions three, four and five (Table 1); other positions showed low spectral count preclud-
ing quantitative assessment. Depending on position, 0–18% Cys were found in Sec positions.
The difference among peptides is likely due to the difference in detection of various peptides by
mass spectrometry, so these numbers should be viewed as estimated levels of Sec/Cys insertion.
Fig 3. Isolation of SelP from culture media of HepG2 cells.Medium samples from HepG2 cells were chromatographed on HisPur resin. Fractions were
analyzed by SDS-PAGE, the gels stained with Coomassie blue (Lower panels) and subjected to Western blotting with anti-SelP antibodies (Upper panels).
Lane 1, initial sample, lane 2, flow-though fraction, lane 3, buffer wash, lane 4–10, elution with a gradient of imidazole from 0 to 200 mM in loading buffer. (A)
HepG2 cells grown on DMEMmedium only (control). (B) HepG2 cells grown on DMEM supplemented with 100 nM Se. (C) HepG2 cells grown on DMEM
supplemented with 1 mM thiophosphate (SPO3). Protein molecular weights markers in kDa are shown on the left. Experimental details are given inMaterials
and Methods.
doi:10.1371/journal.pone.0140353.g003
Table 1. Tryptic Sec-containing peptides of SelP isolated from HepG2media samples.
Sample Tryptic Peptide Cys, % Sec, %
Control TGSAITUQCK 0 100
ENLPSLCSUQGLR 0 100
AEENITESCQUR 18.2 81.8
Selenite TGSAITUQCK 0 100
ENLPSLCSUQGLR 0 100
AEENITESCQUR 0 100
Thiophosphate TGSAITUQCK 100 0
ENLPSLCSUQGLR 100 0
AEENITESCQUR 95.5 4.5
Percent Sec and Cys in SelP peptides was assessed by MS/MS as described in Materials and Methods.
doi:10.1371/journal.pone.0140353.t001
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SelP isolated from cells grown in the presence of 100 nM selenite showed only Sec in Sec posi-
tions. In contrast, SelP from cells maintained in the presence of thiophosphate showed nearly
complete replacement of Sec with Cys in the identified peptides (Table 1). Thus, the Sec/Cys
ratio was regulated by both Se availability and the levels of thiophosphate in cell culture
medium.
Sec and Cys insertion in native human SelP
Our previous data revealed that TR1 isolated from mouse liver had 10% Cys in place of Sec,
even under conditions when mouse diets were supplemented with 0.1 ppm Se [16]. To examine
Cys insertion into native SelP, we analyzed Sec to Cys replacement in SelP isolated from
human donor plasma (S1 Fig). Here, Sec and Cys could be quantified at Sec positions two,
three, four and five (Table 2). Interestingly, Cys insertion was unequal among Sec positions.
Depending on position, up to 8% Sec residues were replaced with Cys, with an average of 4.1%
Cys in place of Sec. Thus, Cys is present naturally in SelP under common dietary conditions.
Discussion
Sec insertion at UGA codons is known to be at competition with termination of protein synthe-
sis [1]. However, the levels of full-length selenoproteins are often viewed as being equivalent
with their selenium content. Although quantification of Se content in selenoproteins pointed
out that it is lower than one atom per Sec site per selenoprotein, it has been assumed that a frac-
tion of Se is lost from selenoproteins under physiological conditions or during protein prepara-
tion. However, we recently showed that Cys can be inserted into TR1 and that up to 10% Sec
sites are occupied by Cys in this selenoprotein in mice fed common rodent chow containing
normal amounts of dietary selenium [16].
A key finding of the present study is that SelP also contains Cys in place of Sec. This is par-
ticularly relevant since SelP is a protein that largely regulates organismal Se homeostasis. This
selenoprotein of exceptional significance has emerged as a biomarker of Se status based on
both animal and human studies. SelP has also been suggested to be a biomarker for prostate
cancer [21,22]. Previous studies revealed the Se content of only 7.5 +/- 1.0 atoms/SelP polypep-
tide that contains 10 predicted Sec sites [14], consistent with the idea that at least some of the
previous discrepancy between the predicted and observed Se content of the protein may be
explained by Cys insertion at the Sec sites.
Depending on the location of Sec within SelP, up to 8% of Sec sites were occupied by Cys in
the selenoprotein isolated from plasma of five healthy donors (S1 Fig), with the average of 4%
Cys across Sec positions. Spectral counts were sufficient to quantify only 4 sites in SelP. Thus,
these numbers represent approximate Cys content of Sec at specific sites. We further found
that this Sec/Cys ratio can both decrease and increase depending on the availability of Se and
the selenophosphate antagonist, thiophosphate, because treatment of HepG2 hepatocytes with
Table 2. Tryptic Sec-containing peptides of SelP isolated from pooled (n = 5) human plasma.
Sec position Tryptic Peptide Sec, % Cys, %
2 SUCCHCR 100 0
3 TGSAITUQCK 91.5 8.5
4 ENLPSLCSUQGLR 97.9 2.1
5 AEENITESCQUR 98.3 1.7
Percent Sec and Cys in SelP peptides was assessed by MS/MS as described in Materials and Methods.
doi:10.1371/journal.pone.0140353.t002
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thiophosphate completely reversed the ratio such that only Cys was detected at certain Sec
positions. This is also consistent with the previously observed regulation of Cys insertion at the
Sec site in TR1. The cell culture conditions used in the current study represent the proof of
principle with regard to Cys insertion at Sec positions in SelP, but do not correspond to physio-
logical conditions, especially when high levels of thiophosphate were used. However, these
studies provide a foundation for further analyses of Cys and Sec in SelP isolated from human
subjects.
The finding of Cys at Sec positions in a key regulator of organismal Se homeostasis is note-
worthy, as Se status may be influenced by dietary status, disease, age and other factors. Thus, Se
availability may be affected, not only at the levels of SelP, but also at the level of Sec insertion
into this protein. This effect will be most pronounced under conditions of Se deficiency, when
the percent of Cys insertion into SelP is higher. It appears that, depending on the abundance of
the non-Sec fraction, the levels of Se provided by SelP may be significantly overestimated in
nutrition research. This raises issues with regard to the analysis and use of SelP as a marker Se
status in human populations. Quantitative assessment of the degree of Sec replacement with
Cys in human subjects differing in genotype, diet, disease status, sex and age would be informa-
tive for further application of this major Se biomarker.
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S1 Fig. Isolation of SelP from human plasma. A plasma pool of 5 human donors was purified
by affinity column isolation. SelP was eluted with citric acid (50 mM, pH 2.0). (A) Elution pro-
file indicating protein-containing fractions. Eluate fractions E2-E6 were pooled. (B) Western
Blot analysis of the eluate-pool yields SelP bands in the expected size range.
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